Advertisement Fidelity
Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

SalutWo are people

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
france Member Profile
 
Followed By 0
Posts 31
Boards Moderated 0
Alias Born 12/03/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/18/2014 11:36:41 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 3:11:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 3:09:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 3:08:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 3:06:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 2:59:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 2:57:11 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 5:08:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/2/2014 2:00:09 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/25/2014 5:43:27 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) "Edgar (US Regulatory)" - 3/20/2014 11:29:59 AM
LifeSci Advisors Initiates Coverage of Oramed Pharmaceuticals "Marketwired" - 3/20/2014 9:30:00 AM
Oramed to Present Results from its Phase 2a FDA Trial with ORMD-0801 at the 2014 Diabetes Summit on April 24, 2014 "PR Newswire (US)" - 3/3/2014 8:20:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/12/2014 5:28:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/12/2014 3:16:26 PM
Oramed Submits Phase 2a Protocol to FDA for the Treatment of Type 1 Diabetes with its Oral Insulin Capsule "PR Newswire (US)" - 2/10/2014 9:47:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/6/2014 4:55:46 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/6/2014 4:22:54 PM
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Oramed Pharmaceuticals, Inc. "PR Newswire (US)" - 2/4/2014 8:45:00 AM
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oramed Pharmaceuticals Inc. - ORMP "PR Newswire (US)" - 2/3/2014 12:51:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/30/2014 11:31:10 AM
Oramed Announces Successful FDA Phase 2a Clinical Trial Results "PR Newswire (US)" - 1/30/2014 4:00:00 AM
Oramed to Announce Results of its Phase 2a Clinical Trial for Oral Insulin on January 30th at the Tel Aviv Stock Exchange "PR Newswire (US)" - 1/27/2014 9:10:00 AM
Oramed Receives Patent Allowance in Israel and Australia for Platform Technology in Oral Delivery of Proteins "PR Newswire (US)" - 1/2/2014 8:20:00 AM
Oramed to Raise $15,800,000 in Registered Direct Offering "PR Newswire (US)" - 12/24/2013 9:12:00 PM
france   Friday, 01/28/11 01:48:59 PM
Re: juda post# 81
Post # of 336 
Salut


Wo are people

Oramed have a great potential

I think...2011...FDA..Nasdaq....

à bientôt
France


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist